Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]

Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]

  Click to enlarge

US FlagUS/Washington: Sandoz Inc., a Princeton, New Jersey establishment, recalls an estimated 636,000 Losartan Potassium Prescription Drug and Ezetimibe Prescription Drug Bottles due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.

CPSC: http://ht.ly/2wC230proqE

Direct link: https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain identified batch/lot numbers.

Continue reading

%d bloggers like this: